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Abstract
Detection by microneutralization of low-titre antibodies (anti-H5 micro-NT titre £1 : 80) against avian inﬂuenza virus (H5N1) is usually
taken to be a false-positive result. In this prospective study of 242 intensive-care unit patients admitted for severe community-acquired
pneumonia, the prevalence of low-titre anti-H5 micro-NT was 2.4%. Prior exposure to poultry was the sole independent risk factor for
these low-titre antibodies (adjusted OR 42.41; 95% CI 22.45–64.51; p <0.001). We suggest that low anti-H5 micro-NT titres be inter-
preted in conjunction with plausible poultry, environmental and human exposure to H5N1.
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Introduction
Although the last human case of avian inﬂuenza (H5N1) in
Thailand occurred in 2006, it is interesting to note that poul-
try have continued to be infected with H5N1 [1–3]. Studies
of H5N1 infection among Thai patients, healthcare workers
and poultry farmers have found that up to 3% of persons
screened with a microneutralization assay have low titres of
antibodies against avian inﬂuenza virus (anti-H5 micro-NT)
[4–6]. Current disease understanding suggests that detection
of anti-H5 micro-NT titres of <1 : 80 is a false-positive result
[1]. We conducted a 4-year prospective study of intensive-
care unit (ICU) patients with community-acquired pneumonia
(CAP) to enhance our disease understanding for patients
with low anti-H5 micro-NT titres.
Materials and Methods
Participants and setting
All patients (‡15 years) admitted to the eight-bed medical
ICU of Thammasat University Hospital with CAP between 1
February 2005 and 31 December 2008 were eligible for
enrolment. The 500-bed tertiary-care hospital serves a 150-
km-radius referral base in central Thailand. The study was
approved by the Thammasat University Hospital institutional
review board. Written or verbal consent was obtained, from
the patient or the next of kin if the patient was not able to
provide consent, prior to enrolment.
H5N1 screening was routinely performed among all ICU
patients admitted with CAP as of 1 February 2005 [4]. Tra-
cheal aspirates were collected for H5N1 testing by reverse-
transcriptase PCR and viral culture. Acute-phase sera for
anti-H5 micro-NT were obtained within 1 week of symptom
onset; convalescence-phase sera were obtained >14 days
after the acute-phase specimens were obtained. Data con-
cerning demographic and clinical features, exposure to prior
immunization (for seasonal inﬂuenza vaccine) and prior inﬂu-
enza infection were collected using structured data collected
from instruments.
A diagnosis of CAP was deﬁned according to the criteria
of the American Thoracic Society [7]. Inclusion was
restricted to patients <50 years of age who survived
>14 days after hospitalization and had low anti-H5 micro-NT
(detected using either inﬂuenza A/Thailand/1(KAN-1)/2004
(H5N1) or A/Thailand/Nong Bua Lumpoo 1 (PT)/2006
(H5N1) as test viruses; see below) in both acute-phase and
convalescence-phase sera. Patients diagnosed with pneumo-
nia >48 h after admission were excluded. In addition,
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persons >50 years of age were excluded, as the anti-H5
micro-NT assay for subtyping of H5N1 is less speciﬁc for
persons in this age group [8].
Microneutralization testing for H5N1
Sera were stored at )20C until being tested under bio-
safety level 3 conditions. Sera were tested for H5-speciﬁc
antibodies using a micro-NT test for H5N1, following
an adapted laboratory protocol, at the Department of
Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol
University [8]. Prior to study initiation, senior laboratory
staff received 2 weeks of on-site training by a visiting scien-
tist from the CDC who had expertise with this assay. The
reactive samples underwent conﬁrmatory western blot test-
ing, using H5-transfected 293T cells as the test antigen, and
inﬂuenza A/Thailand/1(KAN-1)/2004 (H5N1) and A/Thai-
land/Nong Bua Lumpoo 1 (PT)/2006 (H5N1) were both
used as the test viruses [6]. Sera were serially diluted from
1 : 5 to 1 : 80. Haemagglutination inhibition tests for the
KAN-1 and PT strains were performed in all cases with
positive low-titre anti-H5 micro-NT, to detect cross-reac-
tivity with circulating antibodies after prior human inﬂuenza
virus infection. The WHO deﬁnes a positive test result as
an anti-H5 micro-NT titre of >1 : 80 with a conﬁrmatory
western blot [1,4,5,8].
Statistical analysis
Patient demographics were compared using the chi-square
test or Fisher’s exact test. Continuous variables were
compared using the Wilcoxon rank sum test. Multivariable
logistic regressions were performed to identify potential
risk factors associated with low anti-H5 micro-NT titres
(e.g. age, comorbidity, history of poultry exposure, and
duration of poultry exposure). All p-values were two-
tailed; p-values of <0.05 were considered to be statistically
signiﬁcant.
Results
Participants and characteristics of index cases
Two hundred and forty-two of 336 CAP patients (72%) met
the inclusion criteria during the 47-month study period; all
consented to participate in the study, and their diagnosis of
CAP was conﬁrmed. The median age was 40 years (range,
15–50 years), 133 (55%) were male, 52 (21.5%) had exten-
sive poultry exposure (as poultry workers, farmers or butch-
ers), and none had tracheal aspirates positive for H5N1. All
participants had anti-H5 serology titres <1 : 80, and six
participants (2.4%) had low anti-H5 micro-NT titres in
acute-phase and convalescence-phase sera. Anti-H5 micro-
NT titres were 1 : 40 (n = 1), 1 : 20 (n = 3) and 1 : 10
(n = 2). In addition, each of these six participants with anti-
H5 titres <1 : 80 also had negative haemagglutination inhibi-
tion test ﬁndings for seasonal inﬂuenza, and none of them
had a prior history of inﬂuenza vaccination or inﬂuenza infec-
tion in the previous inﬂuenza season. All six participants with
anti-H5 micro-NT titres <1 : 80 were poultry workers and
had worked since the start of the avian inﬂuenza outbreak in
2003 in Thailand. Three of them (50%) reported handling
sick or dying poultry, two (33%) were involved in culling of
apparently healthy poultry in outbreak areas, and one (17%)
reported contact with only healthy poultry in the context of
routine farming practices (Table 1).
Risk factors for positive low micro-NT titre
There were no differences in demographic or clinical charac-
teristics among the six participants who had low (positive)
micro-NT titres from the 236 participants who had negative
micro-NT titres (Table 2). Poultry workers who had low
anti-H5 micro-NT titres had longer daily exposure to poultry
than those with negative titres (8 h vs. 2 h; p 0.02). The four
participants with higher (‡1 : 20) anti-H5 micro-NT titres
TABLE 1. Characteristics of six pneumonia patients with avian inﬂuenza (H5N1) antibody titres <1 : 80 (as detemined by
microneutralization)
Case Age (years)/Sex Poultry exposure
Daily exposure
(h/day)
Acute-phase vs. convalescence-phase micro-NT titres
(KAN-1/PT/western blot)
1 34/M Handled sick poultry 9 (1 : 40/1 : 20/1 : 20) vs. (1 : 40/1 : 20/1 : 20)
2 36/F Handled dying poultry 8 (1 : 20/1 : 10/1 : 20) vs. (1 : 20/1 : 20/1 : 20)
3 38/M Handled sick poultry 8 (1 : 20/1 : 20/1 : 20) vs. (1 : 10/1 : 20/1 : 20)
4 38/F Culled healthy poultry in outbreak area 8 (1 : 10/1 : 20/1 : 20) vs. (1 : 20/1 : 20/1 : 20)
5 40/M Culled healthy poultry in outbreak area 4 (1 : 10/1 : 10/1 : 10) vs. (1 : 10/1 : 10/1 : 10)
6 42/F Handled healthy poultry on farm 2 (1 : 10/1 : 10/1 : 10) vs. (1 : 10/1 : 10/1 : 10)
Micro-NT, microneutralization antibody; KAN-1, inﬂuenza A/Thailand/1(KAN-1)/2004 (H5N1); PT, inﬂuenza A/Thailand/Nong Bua Lumpoo 1 (PT)/2006 (H5N1).
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had longer daily exposure to poultry than the two with
lower (£1 : 10) titres (median, 8 h/day vs. 3 h/day, respec-
tively; p 0.04). In multivariate analysis, exposure to poultry
was the sole risk factor for low anti-H5 micro-NT titres
(adjusted OR 42.41; 95% CI 22.45–64.51; p <0.001).
Discussion
Our understanding of the dynamics of transmission of H5N1
from poultry to humans is complex and incomplete. The
major ﬁnding from this study was low-titre anti-H5 antibod-
ies in six of 242 (2.4%) relatively young ICU patients with
CAP—all of whom had extensive ongoing exposure to poul-
try in an H5N1-endemic setting. These data, along with the
reports of other investigators from Southeast Asia, suggest
that transmission of H5N1 from poultry to humans may have
a broad, if not protean, clinical spectrum of illness as mea-
sured by the seroprevalence of anti-H5 antibodies. In regions
endemic for poultry infection, low anti-H5 micro-NT titres
(<1 : 80) have been detected in up to 3% of study partici-
pants [4–6]. In one population-based study from Vietnam, a
dose–response relationship was noted between poultry
exposure and ﬂu-like illness among persons who had healthy
poultry in the household, those with sick or dead poultry in
the household, and those who had direct contact with sick
poultry [9]. Additionally, in a surveillance study of poultry in
Cambodia, 35% of environmental samples from mud, pond
water, water plants and soil tested positive for H5N1 [10].
Our study ﬁndings of Thai ICU patients with CAP revealed
that over 20% of the study population had extensive poultry
exposure as poultry workers, farmers or butchers, and all
six cases (100%) with low, but detectable, anti-H5 antibodies
were poultry workers or farmers. Detection of a low anti-
H5 antibody titre may represent previous H5N1 exposure,
suggesting that ICU patients with severe CAP have a similar
seroprevalence with respect to H5N1 as has been identiﬁed
for the general population in this same geographical region.
Several plausible hypotheses can be generated to explain
the low anti-H5 micro-NT titres among the CAP cases in
our study. First, these low titres may represent cross-reac-
tivity with circulating antibodies from prior human inﬂuenza
virus infection [1,6]. Second, they may be due to mild or
asymptomatic H5N1 infection, as not all H5N1 infections
result in marked antibody responses [11]. Third, they may
reﬂect a decrease in antibody titres over time [12]. Finally,
they may represent infections with another virus variant,
given that the micro-NT assay is highly sensitive and strain
speciﬁc, and was performed with test virus from the ﬁrst
(KAN-1) and the last (PT) human H5N1 cases in Thailand.
There are some limitations that are worth noting. First, the
small sample size may not have permitted us to identify other
potential factors associated with low anti-H5 micro-NT titres.
Given that follow-up was limited to 14 days after clinical man-
ifestation of CAP, we were not able to assess whether these
low titres reﬂected a decrease in antibody titres over time.
Although it is plausible that low anti-H5 titres result from
either ‘false-positive’ test ﬁndings or cross-reactivity with cir-
culating antibodies from prior human inﬂuenza virus infection
or prior inﬂuenza vaccination, it remains intriguing that all six
participants with low anti-H5 micro-NT titres had both posi-
tive acute-phase and positive convalescence-phase sera when
tested against two different H5N1 strains, and all had exten-
sive poultry exposure. Additionally, in all six cases the results
of haemagglutination inhibition tests for antibody to seasonal
inﬂuenza virus were negative, suggesting a lower likelihood of
cross-reactivity between inﬂuenza subtypes.
TABLE 2. Demographic and clinical characteristics of hospi-
talized adults with severe community-acquired pneumonia
(CAP) stratiﬁed by detection of anti-H5 microneutralization
antibody (micro-NT) titres at a tertiary-care centre in an
H5N1-endemic region of Thailand
Characteristic
Anti-H5 micro-NT
p-Valuea
Low
positive
titre (n = 6)
Negative
titre
(n = 236)
Age (years), median (range) 38 (34–42) 39 (15–50) 0.71
Sex (male) 3 (50) 130 (55) 0.80
Comorbid condition (median no., range) 1 (0–3) 2 (0–5) 0.15
APACHE-II score 15 (10–21) 16 (9–22) 0.78
History of prior inﬂuenza vaccination 0 (0) 2 (0.8) 0.91
History of prior inﬂuenza infection 0 (0) 6 (2.5) 0.84
History of poultry exposure 6 (100) 46 (19.5) <0.001
Poultry exposure per day (median, h) 8 3 0.02
Exposure to case with H5N1 0 0 NA
History of recent travel 0 0 NA
Met deﬁnition of probable H5N1b 2 (33) 36 (15) 0.24
Initial CAP symptomsc
Pulmonaryd 6 (100) 210 (89) 0.83
Gastrointestinale 3 (50) 112 (47)
Neurologicalf 1 (17) 37 (16)
Other 1 (17) 40 (17)
APACHE-II, Acute Physiology and Chronic Health Evaluation-II; NA, not
applicable.
Data are numbers (%), unless indicated otherwise.
All p-values were two-tailed; p <0.05 was considered signiﬁcant.
aIncluded drowsiness, confusion, and coma.
bWithin 1 year prior.
cThe current Thai national surveillance deﬁnition for probable H5N1 included:
(i) presence of fever (>38C); (ii) inﬂuenza-like illness; (iii) exposure to sick
poultry or residence in the disease-endemic areas with excess poultry death
rates; and (iv) radiographic evidence of severe CAP without an identiﬁed aetio-
logical agent.
dMost patients had multiple underlying diseases and initial clinical symptoms, so
the sums of all percentages are >100%.
eIncluded cough, dyspnoea or tachypnoea, rigor and/or chills, pleuritic chest
pain, purulent sputum, or changes in the characteristics of sputum, and ausculta-
tory ﬁndings.
fIncluded diarrhoea, and/or nausea or vomiting, and abdominal tenderness.
Categorical variables were compared using a chi-square test or Fisher exact
test, as appropriate; continuous variables were compared using the Wilcoxon
rank sum test or t-test, as appropriate.
1356 Clinical Microbiology and Infection, Volume 16 Number 9, September 2010 CMI
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 1354–1357
In conclusion, we report the detection of low anti-H5
micro-NT titres in six ICU patients with CAP—each of
whom identiﬁed himself as either a poultry worker or a
poultry farmer. Detection of low anti-H5 micro-NT titres in
ICU patients with severe CAP may indicate prior H5N1
exposure and not acute viral infection. We suggest that low
anti-H5 micro-NT titres be interpreted in conjunction with
plausible poultry, environmental and human exposures to
H5N1. Additional studies are needed to enhance our under-
standing of anti-H5 seroprevalence in healthy and ill popula-
tions and to determine whether low anti-H5 micro-NT
titres are insigniﬁcant or representative of host immune
responses to H5N1 exposure.
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